PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts history by more than $90 million, according to the Boston Business Journal Wednesday.
The company had previously projected a $200 million IPO. The previous highest IPO for a biotech company in the Bay State was $153 million for Kiniska Pharmaceuticals.
A Simplified Approach to Designing and Implementing Internal Control in the Hospitality Industry
In my previous article, Internal Controls & Audits: Keys to a Resilient Hospitality Business, I…
Learn More
The company recently was approved for $9 million in incentives from Rhode Island to open a pharmaceutical manufacturing plant in Smithfield.
The company was recently estimated to be worth $2 billion and was reported to have 83 employees in a filing in June.
